$NVCR NovoCure Ltd Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NovoCure Ltd.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in NovoCure Ltd. Insider overview, share value development, latest insider transactions and email notifications about new events in NovoCure Ltd for free.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Trading Symbol: NVCR
Company Address: NO. 4 THE FORUM GRENVILLE STREET ST. HELIER JE2 4UF
Former name: Novocure Ltd, date of change: 2015-06-15
Market Capitalization: $581.43M
Prev close: $6.80
Average Daily Volume: 408,606
Days Low: $6.60
Year Low: $5.95
Year High: $18.72
NovoCure Ltd Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 11 2021 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Option Exercise | A | 211.89 | 1,499 | 317,623 | 1,499 | |
| Jun 11 2021 | NVCR | NovoCure Ltd | McCoy Sherilyn S | Director | Grant | A | 0.00 | 814 | 0 | 6,714 | 5.9 K to 6.7 K (+13.80 %) |
| May 14 2021 | NVCR | NovoCure Ltd | Benaim Ely | Chief Medical Offic ... | Sell | S | 180.48 | 1,943 | 350,673 | 29,054 | 31 K to 29.1 K (-6.27 %) |
| May 12 2021 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Option Exercise | M | 47.56 | 3,846 | 182,916 | 3,845 | |
| May 12 2021 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Sell | S | 189.65 | 1,804 | 342,129 | 31,667 | 33.5 K to 31.7 K (-5.39 %) |
| May 12 2021 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Sell | S | 189.65 | 3,846 | 729,394 | 33,471 | 37.3 K to 33.5 K (-10.31 %) |
| May 12 2021 | NVCR | NovoCure Ltd | Weinberg Uri | Chief Science Offic ... | Buy | M | 47.56 | 3,846 | 182,916 | 37,317 | 33.5 K to 37.3 K (+11.49 %) |
| May 06 2021 | NVCR | NovoCure Ltd | Shah Pritesh | Chief Commercial Of ... | Sell | S | 199.67 | 1,290 | 257,574 | 101,272 | 102.6 K to 101.3 K (-1.26 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 216.69 | 600 | 130,016 | 555,393 | 556 K to 555.4 K (-0.11 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 214.67 | 500 | 107,333 | 555,993 | 556.5 K to 556 K (-0.09 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 213.35 | 1,500 | 320,021 | 556,493 | 558 K to 556.5 K (-0.27 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 211.28 | 600 | 126,766 | 557,993 | 558.6 K to 558 K (-0.11 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 210.18 | 521 | 109,504 | 558,593 | 559.1 K to 558.6 K (-0.09 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 209.34 | 2,200 | 460,555 | 559,114 | 561.3 K to 559.1 K (-0.39 %) |
| Apr 15 2021 | NVCR | NovoCure Ltd | DOYLE WILLIAM F | Executive Chairman | Sell | S | 207.80 | 4,500 | 935,118 | 561,314 | 565.8 K to 561.3 K (-0.80 %) |